SEI区块链在后者的第11章破产后获取23andMe

可以说，SEI在X帖子中透露，它正在收购23andMe“捍卫1500万美国人的遗传隐私并确保其数据得到保护

A significant bet towards the developing concept of decentralised science, Sei Blockchain has announced the acquisition of 23andMe after the latter filed for Chapter-11 Bankruptcy.

SEI区块链是针对分散科学发展概念的一个重要下注，在后者提出第11章破产后，宣布了23AndMe的收购。

California-based genetic testing and biotech company 23andMe has been offering DNA testing via saliva samples for millions of Americans since 2007.

自2007年以来，总部位于加利福尼亚的基因测试和生物技术公司23andMe一直在通过唾液样品为数百万美国人提供DNA测试。

Arguably, Sei revealed in a X post that it is acquiring 23andMe “to defend the genetic privacy of 15 million Americans and ensure their data is protected for generations to come.”

可以说，SEI在X帖子中透露，它正在收购23andme“捍卫1500万美国人的遗传隐私，并确保其数据受到后代的保护。”

Coming amidst the financial vulnerabilities of 23andMe, Chapter 11 bankruptcy under the U.S. Bankruptcy Code allows businesses (and sometimes individuals) to reorganize their debts while continuing operations.

在《 23andme的财务漏洞》中，《美国破产法》第11章破产使企业（有时甚至是个人）在继续运营的同时重新组织债务。

Decoding the Sei Blockchain’s 23andMe Acquisition

解码SEI区块链的23andMe收购

Sei Blockchain has called the genetic data privacy as a national security concern. As per the 23andMe acquisition update, Sei is aiming to bring all the genetic data collected by 23andMe over the years on the Sei Blockchain.

SEI区块链将遗传数据隐私视为国家安全问题。根据23AndMe的收购更新，SEI的目标是将23AndMe在SEI区块链上收集的所有遗传数据。

It will further return data ownership to users through encrypted, confidential transfers.

它将通过加密的保密转移将数据所有权进一步返回给用户。

Notably, Blockchain’s immutable and decentralized nature can reduce the risk of unauthorized access and data breaches.

值得注意的是，区块链不变的和分散的性质可以降低未经授权的访问和数据泄露的风险。

With Sei Blockchain’s acquisition, users will also have opportunities to monetize their data by either consenting to participate in research studies or share information with pharmaceutical companies. Since all the transactions will be transparently recorded on the blockchain, users can be contended about security.

通过SEI区块链的收购，用户还将有机会通过同意参与研究研究或与制药公司共享信息来获利。由于所有交易将在区块链上透明地记录下来，因此可以争议用户有关安全性。

As 23andMe approaches Bankruptcy, several attorney generals including NY Attorney General Letita James have already asked the firm to delete the genetic data of millions of Americans that it has collected over the years.

随着23AndMe的破产，包括纽约州司法部长莱蒂塔·詹姆斯（Letita James）在内的几位律师将军已经要求该公司删除多年来收集的数百万美国人的遗传数据。

Its stock price has also declined by 59% after the bankruptcy announcement, with many users already starting to delete their accounts.

破产公告后，其股价也下降了59％，许多用户已经开始删除其帐户。

On the contrast, recently, Donald Trump’s DeFi project World Liberty Financial acquired another 541,242 SEI coins, pushing the SEI price up by 7.3%.

相比之下，最近，唐纳德·特朗普（Donald Trump）的Defi Project World Financial收购了另外541,242 SEI硬币，将SEI价格提高了7.3％。

As revealed in the Bankruptcy notice, Anne Wojcicki has also resigned from her role as Chief Executive Officer, effective immediately, by mutual agreement between Ms. Wojcicki and the Special Committee.

正如《破产通知》中揭示的那样，安妮·沃吉奇（Anne Wojcicki）也辞去了首席执行官的职务，立即通过沃吉基（Wojcicki）女士与特别委员会之间的相互协议生效。

But What lead 23andMe to go Bankrupt?

但是，什么导致23andme破产呢？

In 2007, 23andMe became the first company to offer at-home genetic testing, allowing individuals to send a saliva sample for DNA analysis.

2007年，23AndMe成为第一家提供在家基因测试的公司，使个人可以发送唾液样本进行DNA分析。

However, once a leader in at-home DNA testing is set to be acquired by Sei Blockchain after 23andMe filed for Chapter 11 bankruptcy on March 23.

但是，一旦在23AndMe于3月23日提交第11章破产后，SEI区块链将被SEI区块链收购。

Initially, the company saw strong sales, but interest in genetic testing waned, leading to unsustainable revenue. Despite securing major investments, including $300 million from GlaxoSmithKline and a $3.5 billion valuation upon going public in 2021, 23andMe failed to develop a recurring revenue model.

最初，该公司的销售强劲，但对基因检测的兴趣减弱，导致不可持续的收入。尽管获得了重大投资，其中包括葛兰素史克的3亿美元，并在2021年公开时获得了35亿美元的估值，但23AndMe未能开发出重复的收入模型。

The company also faced reputational damage due to a 2023 data breach that compromised 6.9 million customer records, leading to lawsuits and eroding consumer trust. Additionally, a costly $400 million acquisition of Lemonaid Health in 2021 did not yield expected financial returns.

由于2023年的数据泄露，该公司还遭受了声誉损失，损害了690万个客户记录，导致诉讼和侵蚀消费者信任。此外，2021年对LemonAID Health的4亿美元收购并未产生预期的财务回报。

Internal leadership struggles further contributed to instability with the entire independent board resigning in late 2024. And now as part of its bankruptcy filing, 23andMe is now looking to sell its genetic database – the opportunity that Sei Blockchain is aiming to seize.

内部领导层的斗争进一步促进了整个独立董事会在2024年底辞职的不稳定。现在，作为其破产申请的一部分，23andme现在希望出售其遗传数据库 - SEI区块链旨在抓住的机会。

Pioneering move for DeSci?

开创性的动作？

By integrating 23andMe’s genetic records onto the Sei blockchain, the Sei foundation can provide users with secure, encrypted control over their personal information.

通过将23andMe的遗传记录集成到SEI区块链上，SEI基金会可以为用户提供对其个人信息的安全，加密的控制。

This approach also aligns with the principles of Decentralized Science (DeSci), which seeks to apply blockchain technology to scientific research and data management. This notably helps in promoting transparency and user empowerment.

这种方法还符合分散科学（DESCI）的原则，该原理试图将区块链技术应用于科学研究和数据管理。这特别有助于促进透明度和授权。

However, ensuring the accurate and secure transfer of vast amounts of sensitive genetic data to the Sei blockchain would be a daunting task for Sei.

但是，确保将大量敏感遗传数据的准确转移到SEI区块链中是SEI的艰巨任务。

But if successful, this endeavor could redefine data ownership and privacy in the genomic era, and empower individuals with unprecedented control over their most personal information – GENETIC!

但是，如果成功的话，这项努力可以重新定义基因组时代的数据所有权和隐私，并赋予对自己最个人化信息的前所未有控制的个人 - 遗传！